Cargando…

The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical Testing

Chimeric antigen receptor (CAR) T cells targeting CD123, an acute myeloid leukemia (AML) antigen, hold the promise of improving outcomes for patients with refractory/recurrent disease. We generated five lentiviral vectors encoding CD20, which may serve as a target for CAR T cell depletion, and 2(nd)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riberdy, Janice M., Zhou, Sheng, Zheng, Fei, Kim, Young-In, Moore, Jennifer, Vaidya, Abishek, Throm, Robert E., Sykes, April, Sahr, Natasha, Bonifant, Challice L., Ryu, Byoung, Gottschalk, Stephen, Velasquez, Mireya Paulina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393323/ https://www.ncbi.nlm.nih.gov/pubmed/32775492 http://dx.doi.org/10.1016/j.omtm.2020.06.024

Ejemplares similares

Transgenic Expression of IL15 Retains CD123-Redirected T Cells in a Less Differentiated State Resulting in Improved Anti-AML Activity in Autologous AML PDX Models
por: Mu-Mosley, Hong, et al.
Publicado: (2022)

Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 co-stimulation
por: Vaidya, Abishek, et al.
Publicado: (2022)

Adoptive immunotherapy for AML with CD123-engager T cells
por: Bonifant, Challice, et al.
Publicado: (2015)

T cells expressing CD19-specific Engager Molecules for the Immunotherapy of CD19-positive Malignancies
por: Velasquez, Mireya Paulina, et al.
Publicado: (2016)

T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC
por: Szoor, Arpad, et al.
Publicado: (2017)

Harnessing T Cells to Target Pediatric Acute Myeloid Leukemia: CARs, BiTEs, and Beyond
por: Epperly, Rebecca, et al.
Publicado: (2020)

Epitope tagging of endogenous genes in diverse human cell lines
por: Kim, Jung-Sik, et al.
Publicado: (2008)

Toxicity and management in CAR T-cell therapy
por: Bonifant, Challice L, et al.
Publicado: (2016)

Unifying heterogeneous expression data to predict targets for CAR-T cell therapy
por: Schreiner, Patrick, et al.
Publicado: (2021)

CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?
por: Tettamanti, Sarah, et al.
Publicado: (2014)

Work efficiency improvement of >90% after implementation of an annual inpatient blood products administration consent form
por: Lindsay, Holly, et al.
Publicado: (2018)

CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells
por: Hebbar, Nikhil, et al.
Publicado: (2022)

Decitabine-Mediated Epigenetic Reprograming Enhances Anti-leukemia Efficacy of CD123-Targeted Chimeric Antigen Receptor T-Cells
por: You, Liangshun, et al.
Publicado: (2020)

CAR-NK Cells Targeting Sars-Cov-2 Glycosites As COVID-19 Treatment
por: Christodoulou, Ilias, et al.
Publicado: (2021)

Chimeric antigen T cell receptor treatment in hematological malignancies
por: Ali, Natasha
Publicado: (2019)

Glycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection
por: Christodoulou, Ilias, et al.
Publicado: (2021)

Improved Activity against Acute Myeloid Leukemia with Chimeric Antigen Receptor (CAR)-NK-92 Cells Designed to Target CD123
por: Morgan, Michael A., et al.
Publicado: (2021)

Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors
por: Mata, Melinda, et al.
Publicado: (2019)

Chimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activity
por: Chan, W K, et al.
Publicado: (2015)

Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions
por: Greenbaum, Uri, et al.
Publicado: (2020)

Treatment of leukemia antigen-loss relapses occurring after CD19-targeted immunotherapies by combination of anti-CD123 and anti-CD19 chimeric antigen receptor T cells
por: Ruella, Marco, et al.
Publicado: (2015)

Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives
por: Podestà, Manuel Alfredo, et al.
Publicado: (2022)

Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis
por: Villamizar, Olga, et al.
Publicado: (2016)

Individualized recombinant human thrombomodulin (ART-123) administration in sepsis patients based on predicted phenotypes
por: Hasegawa, Daisuke, et al.
Publicado: (2019)

An Experience of Multiple Hematomas in a Coronavirus Disease-19 Patient Administered with ART-123 and Heparin
por: Shiraki, Hideto, et al.
Publicado: (2021)

MON-123 Atypical Diabetes Mellitus or Type 1 Diabetes Mellitus?
por: Havrylyan, Andriy, et al.
Publicado: (2019)

Design and Production An Effective Bispecific Tandem Chimeric Antigen Receptor on T Cells against CD123 and Folate Receptor ß towards B-Acute Myeloid Leukaemia Blasts
por: Ghamari, Ali, et al.
Publicado: (2021)

Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity
por: Wang, Zhenzhen, et al.
Publicado: (2023)

A Bump in the Road: How the Hostile AML Microenvironment Affects CAR T Cell Therapy
por: Epperly, Rebecca, et al.
Publicado: (2020)

Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma
por: McKenna, Mary K, et al.
Publicado: (2023)

Low-Molecular Weight Polyethylenimine Modified with Pluronic 123 and RGD- or Chimeric RGD-NLS Peptide: Characteristics and Transfection Efficacy of Their Complexes with Plasmid DNA
por: Hu, Jing, et al.
Publicado: (2016)

Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of V(L) and V(H) Domains Targeting CD123(+) Tumors
por: Thokala, Radhika, et al.
Publicado: (2016)

Opus 123
por: Arredondo, Inés
Publicado: (1988)

New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future
por: Biagi, Ettore, et al.
Publicado: (2011)

Engineering Chimeric Antigen Receptors
por: Kulemzin, S. V., et al.
Publicado: (2017)

Abdominal Tumor Mistaken for Pregnancy
por: Challice, John
Publicado: (1848)

An Early CD4(+) T Cell–dependent Immunoglobulin A Response to Influenza Infection in the Absence of Key Cognate T–B Interactions
por: Sangster, Mark Y., et al.
Publicado: (2003)

Costimulation to enhance the antitumor activity of CD19 eng T cells
por: Velasquez, Mireya, et al.
Publicado: (2015)

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
por: Grada, Zakaria, et al.
Publicado: (2013)

Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead
por: Pasvolsky, Oren, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6o6jpsva7q9mgfve9vn2r63ehm